Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. (Q48184250)
Jump to navigation
Jump to search
scientific article published in May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. |
scientific article published in May 2015 |
Statements
Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1 (English)
Naveen Pemmaraju
Jorge E Cortes
Raja Luthra
Hagop M Kantarjian